Aniara | Shaping the Future with Innovative Solutions
 
 Search
 

Learning Center

Hemostasis Happenings


Thursday, May 6, 2010

HEMOSTASIS HAPPENINGS: MAY 2010

12th Annual Symposium on Hemostasis and Thrombosis

Midwest Coag Hemostasis and Thrombosis Laboratories
www.midwestcoag.com

When: Thursday, May 6 and Friday, May 7, 2010
Where: Westin Hotel, Downtown Indianapolis, Indiana
Presented By: Midwest Coag and Esoterix Coagulation


International Society for Laboratory Hematology (ISLH)

May 10-12, 2010
www.islh.org

PM: II. Haemostasis

Bruce Furie (USA) - Thrombus formation in vivo.
Paula Bolton Maggs (UK) - Rare bleeding disorders: Are they under-diagnosed?
Paul Harrison (UK) - Will detection of microparticles have clinical utility?
Marcel Levi (Netherlands) - Disseminated intravascular coagulation: Which laboratory tests are most useful?

AM: IV. Point of Care (Haemostasis)

Chris Gardiner (UK) - Point of careINR Testing: What monitors are currently available?
Dianne Kitchen (UK) - How should point of care international normalized ratio monitors be quality controlled?
Steve Kitchen (UK) - Agreement between laboratory and point of care international normalized ratio: What should we expect?
Alistair Nimmo (UK) - Haemostasis testing in the operating theatre.

PM: VI. Oral Anticoagulant Therapy

David Fitzmaurice (UK) - Patient self-testing and self-management of vitamin K antagonist therapy.
Jack Ansell (USA) - Managing vitamin K antagonist therapy: Patient self-management or traditional care?
Sam Machin (UK) - Warfarin therapy: What is the prognosis?
Chuck Eby (USA) - Pharmacogenetic and clinical factors to predict the dose of warfarin.


6th International Platelet Symposium

May 14-18, 2010
www.platelets2010.com
 
The Platelets 2010 program will include sessions on:

  • Platelet development
  • Platelet activation
  • Platelet signaling
  • Platelet adhesion
  • Platelet function testing
  • Genetic disorders, including functional genomics
  • Platelets in inflammation and atherosclerosis
  • Immune platelet disorders, including ITP, TTP, HIT
  • Platelet microparticles
  • Pharmacology I
  • Pharmacology II

 


56th Annual Meeting of the Scientific and Standardization Committee (SSC)
International Society on Thrombosis and Haemostasis  (ISTH)

May 22-25, 2010
www.ssc2010.org

Grand Hyatt Hotel
Corniche El-Nil, PO Box 2288
Garden City – Roda Island, Cairo, Egypt

Saturday, 22 May, 2010

Educational Session

9:00 - 10:30

  • Venous thrombosis 1
    Chairmen:  Mike Greaves, UK; Amr Gad, Egypt
    • The central role of protein S in regulation of coagulation. Tilman Hackeng, The Netherlands
    • What is the benefit of testing for heritable thrombophilia? Trevor Baglin, UK
    • Prevention of VTE in the hospitalised patient: the evidence. Mike Greaves, UK
  • Hereditary bleeding disorders
    Chairmen:  Alok Srivastava, India; Amal El Beshlawy, Egypt
    • Hemophilia.  The Pia Glas-Greenwalt Memorial Lecture.  Alok Srivastava, India
    • Rare bleeding disorders.  Flora Peyvandi, Italy
    • Von Willebrand Disease.  William Nichols, USA

Presidential Plenary

11:00 - 12:30

  • Chairman:  Nevine Kassim, Egypt
    • Current views on cause of first and recurrent venous thrombosis.  Frits Rosendal, Nertherlands
    • New antiplatelet agents.  Marco Cattaneo, Italy
    • Inhibitor development and choice for plasma vs recombinant factor VIII products.  Anske van der Bom, The Netherlands and Johannes Oldenburg, Germany
    • Abolishing ALL FFP. Trevor Baglin, UK

Educational Session

14:30 - 16:00

  • Venous thrombosis 2
    Chairmen:  Sam Schulman, Canada; Sherif El Shalkany, Egypt
    • Diagnosis, management & duration of therapy in thrombotic disorders.  Henri Bounameaux, Switzerland
    • Management of vitamin K antagonists.  Felix van der Meer, The Netherlands
    • New issues in oral anticoagulation.  Sam Schulman, Canada
  • Women's Issues
    Chairmen:  Flora Peyvandi, Italy; Andra James, USA
    • The thrombotic risk associated with oral contraceptive use.  Astrid Van Hylckama, The Netherlands
    • The risk of recurrence of thrombotic thrombocytopenic purpura in congenital and acquired AD13 deficient women.  Flora Peyvandi, Italy
    • Management of pregnancy in women affected with coagulation disorders.  Rezan Kadir, UK

Education Session

16:30 - 18:00

  • Laboratory Quality Management in limited health resourced countries
    Chairmen:  Steve Kitchen, UK; Francis E Preston, UK
    • Preanalytical variables in haemostasis testing.  Steve Kitchen, UK
    • EQA in low resourced countries.  Alok Srivastava, India
    • Quality management in haemostasis.  John Olson, USA
  • Specific issues in countries with limited health resources
    Chairmen:  Tareef Hamza Sallam, Egypt ; Naguib Zoheir, Egypt
    • Use of laboratory tests to  approach a diagnosis in thrombosis & hemostasis.  The Marion Barnhart Memorial Lecture.  Raul Altman, Argentina
    • Safe replacement therapy.  Magdy El Ekiaby, Egypt
    • How to build up scientific thinking in developing countries.  The Shirley Johnson Memorial Lecture.  Emin Kansu, Turkey

 


Sunday, 23 May, 2010

Meet the Expert Session

8:00 - 8:45

  • Hemostasis & liver disease.  Cheng-Hock Toh, UK
  • Pediatric thrombosis.  Guy Young, USA

Educational Session

9:00 - 10:3

  • Antiphospholipid syndrome
    Chairmen:  Ph de Groot, The Netherlands; Mohamed Momtaz, Egypt
    • The serolological criteria that determine the presence of APS.  Armando Tripodi, Italy
    • How do antiphospholipid antibodies increase the risk of thrombosis and fetal loss.  Ph G. de Groot, The Netherlands
    • How I treat APS.  Vittorio Pengo, Italy
  • Idiopathic Thrombocytopenic Purpura (ITP)
    Chairmen:  Andreas Greinacher, Germany; Mohsen El Alfy, Egypt
    • Pathogenesis of ITP. Douglas Cines, USA
    • Acute ITP and management of acute major bleeding in ITP. Betrand Godeau, France
    • Chronic ITP with a special focus on virus infection associated ITP. Howard Liebman, USA

Educational Session

11:00 - 12:3

  • Arterial disease and platelet therapy
    Chairmen:  Alan Nurden, France; Mohamed Ali Taher, Egypt
    • Do we need to monitor patients on treatment with clopidogrel?  Marco Cattaneo, Italy
    • Ticagrelor:  PLATO and beyond.  Robert Storey, UK
    • Thrombocytopenia in a cardiovascular disease setting.  Alan Nurden, France
  • Interactive discussion of case histories
    Chairmen:  Hadi Goubran, Egypt; Pier Mannucci, Italy; Robert Montgomery, USA

 


The 130th Meeting of the Association of Clinical Scientists will be held in San Antonio, Texas, from Wednesday, 12 May, to Sunday, 16 May 2010. The headquarters will be the Historic Wyndham St. Anthony Hotel, located in downtown San Antonio, a few steps from the famous River Walk. The meeting will be hosted by the University of Texas Health Science Center-San Antonio. Drs. Robert L. Reddick and Robert L. Hunter, Jr., Co-Chairs of the Program Committee, cordially invite you to attend.

Session B: Hematology
(Chairs: Jonathan S. Krauss & Robert F. Reiss)
10:30 am    [6] Acquired von Willebrand disease: laboratory diagnosis and therapy. John Lazarchick, Charleston, SC
11:00 am    [7] Transfusion-related alloantibodies in sickle cell disease. Jonathan S. Krauss, Augusta, GA
11:30 am    [8] Utility and limitations of thromboelasto-graphy in the management of coagulation disorders. Jun Teruya, Houston, TX
11:45 am    [9] Activated protein C resistance screening prior to testing for factor V Leiden mutation. Frederick L. Kiechle et al., Hollywood, FL


AMERICAN SOCIETY FOR CLINICAL PATHOLOGY

2010 Baltimore Workshops for Laboratory Professionals
Date: May 11-14, 2010
Location: Baltimore, MD
Credits: Earn up to 7.0 CMLE in a single day


THURSDAY, MAY 13

5799 Down and Dirty Coagulation – Practical Solutions and Answers!
Donna D. Castellone, MS, MT(ASCP)SH

Sheraton Baltimore City Center
101 West Fayette Street
Baltimore, MD 21201
410.752.1100

Donna Castellone

Bookmark and Share

 

About the Author

Donna Castellone,  MS, MT(ASCP)SH

Donna Castellone,
MS, MT(ASCP)SH

View Complete Profile


Links


Previous Posts


Archives

RSS Feed

 
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
Aniara